The HbA1c finger prick test is a quick, convenient blood test that measures your average blood glucose levels over the preceding two to three months, making it a key tool in diagnosing and managing diabetes. Rather than capturing a single snapshot of blood sugar, it reflects long-term glucose control by measuring glycated haemoglobin in red blood cells. Used widely across NHS primary care settings, the test requires no fasting and delivers results within minutes when analysed by a point-of-care device. This article explains how the test works, what your results mean, and what steps to take next, in line with current NICE and NHS guidance.

What Is the HbA1c Finger Prick Test and How Does It Work?

The HbA1c finger prick test measures the proportion of glycated haemoglobin in red blood cells to reflect average blood glucose over two to three months. Point-of-care results must be confirmed with a laboratory venous sample before diagnosing diabetes.

The HbA1c finger prick test is a simple blood test used to measure your average blood glucose (sugar) levels over the preceding two to three months. Unlike a standard blood glucose reading, which only reflects your sugar level at a single point in time, HbA1c provides a broader picture of long-term glucose control — making it a cornerstone tool in the diagnosis and management of diabetes.

The test works by measuring the proportion of haemoglobin — the protein in red blood cells that carries oxygen — that has become glycated, meaning glucose has attached to it. Because red blood cells have a lifespan of approximately 90 to 120 days, the HbA1c level reflects average blood glucose across that period. The result is expressed as a percentage or in millimoles per mole (mmol/mol), with the latter being the standard unit used in the UK (aligned with IFCC — International Federation of Clinical Chemistry — standardisation).

In a finger prick version of the test, a small lancet device is used to obtain a tiny drop of blood from the fingertip. This sample is then analysed either by a point-of-care (POCT) device in a GP surgery or pharmacy, or sent to a laboratory. Point-of-care HbA1c testing has become increasingly common in primary care settings, offering results within minutes rather than days, which can support faster clinical decision-making and improve patient engagement.

However, it is important to understand that for the purpose of diagnosing diabetes, NICE and NHS guidance recommend that HbA1c should be measured on a venous blood sample analysed in an IFCC-aligned, quality-assured laboratory. A finger prick point-of-care result alone should not be used to confirm a new diagnosis of diabetes; any abnormal POCT result should be confirmed with a laboratory venous sample. POCT devices used in clinical settings must meet quality assurance standards and be regularly calibrated, in line with MHRA guidance on the management and use of in vitro diagnostic point-of-care test devices.

When Might You Be Offered This Test on the NHS?

The NHS offers HbA1c testing to diagnose type 2 diabetes, screen for prediabetes, and monitor existing diabetes, but it is not appropriate in pregnancy, children, or where red blood cell turnover is abnormal.

On the NHS, the HbA1c test is used in several clinical contexts, and you may be offered it for a variety of reasons depending on your health history and risk profile.

Common reasons for being offered an HbA1c test include:

• Diagnosing type 2 diabetes — if you have symptoms such as increased thirst, frequent urination, unexplained weight loss, or fatigue

• Screening for non-diabetic hyperglycaemia (NDH) — sometimes called prediabetes, if you are at elevated risk due to factors such as obesity, a family history of type 2 diabetes, or a previous diagnosis of gestational diabetes

• Routine monitoring — if you already have a diagnosis of type 1 or type 2 diabetes, to assess how well your blood glucose is being managed

• NHS Health Checks — offered to adults aged 40 to 74 in England, which may include an HbA1c test if risk factors are identified

NICE guidelines (NG28 and NG17) recommend HbA1c testing as the preferred diagnostic method for type 2 diabetes in adults. For monitoring, NICE recommends measuring HbA1c every three to six months until blood glucose levels are stable, then at least every six months thereafter for adults with type 2 diabetes. For adults with type 1 diabetes, HbA1c is usually measured every three months.

HbA1c is not appropriate for diagnosis in the following situations:

• Children and young people

• Pregnancy (including suspected gestational diabetes — an oral glucose tolerance test is used instead)

• Suspected type 1 diabetes, or where symptoms have been present for fewer than two months

• Acute illness

• People taking medicines that can cause rapid changes in blood glucose (such as high-dose corticosteroids or certain antipsychotic medicines)

• Conditions affecting red blood cell turnover, such as haemoglobinopathies, haemolytic anaemia, or recent blood transfusion

• Advanced chronic kidney disease (CKD)

In these situations, alternative tests such as fasting plasma glucose or an oral glucose tolerance test (OGTT) will be used instead.

Your GP, practice nurse, or diabetes specialist may request the test as part of a structured review. In some areas, community pharmacies also offer HbA1c finger prick testing; however, availability varies — some services are locally NHS-commissioned whilst others are offered privately. It is worth checking with your local pharmacy or GP practice what is available in your area.

How to Prepare and What to Expect During the Test

No fasting is required before an HbA1c test; a lancet makes a brief fingertip puncture and point-of-care results are available within five to ten minutes. Inform your clinician of any recent illness, blood transfusion, or relevant medical conditions beforehand.

One of the practical advantages of the HbA1c test — whether performed via finger prick or venous blood draw — is that it does not require fasting beforehand. Unlike fasting glucose tests, you can eat and drink normally before your appointment, which makes it more convenient and accessible for most people.

Before the test, it is helpful to:

• Inform your clinician of any recent illnesses, blood transfusions, or changes in medication, as these can affect the result

• Wash and warm your hands beforehand if you are having a finger prick test, as this improves blood flow and makes sample collection easier

• Let your healthcare professional know if you have any conditions affecting your red blood cells, such as sickle cell anaemia, thalassaemia, or haemolytic anaemia, as these may make HbA1c unsuitable for diagnosis or monitoring

During the test itself, a healthcare professional will clean your fingertip with an alcohol wipe and use a small, spring-loaded lancet to make a brief, shallow puncture. A tiny drop of blood is collected — usually into a small capillary tube or directly onto a test strip. The discomfort is minimal and typically lasts only a second or two.

If the sample is being analysed by a point-of-care device, results are usually available within five to ten minutes. If the sample is sent to a laboratory, results typically return within one to two working days. Your clinician will discuss the findings with you, either at the appointment or via a follow-up consultation.

If your point-of-care result is abnormal and a new diagnosis is being considered, your clinician may arrange a venous blood sample to be sent to a laboratory for confirmation. This is standard practice and does not mean anything is wrong with the initial test — it simply ensures the most accurate result is used for any diagnostic decision.

Understanding Your HbA1c Results and NICE Guidelines

In the UK, an HbA1c below 42 mmol/mol is normal, 42–47 mmol/mol indicates non-diabetic hyperglycaemia, and 48 mmol/mol or above is diagnostic of type 2 diabetes. Monitoring targets are individualised, typically 48–53 mmol/mol depending on treatment and hypoglycaemia risk.

HbA1c results in the UK are reported in mmol/mol, though some older resources may still reference percentage values. Understanding what your result means is essential for informed decision-making about your health.

NICE-aligned HbA1c thresholds are as follows:

• Below 42 mmol/mol (6.0%) — Normal range; diabetes is unlikely

• 42–47 mmol/mol (6.0–6.4%) — Non-diabetic hyperglycaemia (NDH), sometimes referred to as prediabetes; indicates an increased risk of developing type 2 diabetes

• 48 mmol/mol (6.5%) or above — Diagnostic of type 2 diabetes (when confirmed on a second test in the absence of symptoms, or on a single test if symptoms are present)

For people already diagnosed with diabetes, NICE (NG28) recommends individualised HbA1c targets. For most adults with type 2 diabetes managed with lifestyle changes or metformin alone — medicines that do not carry a risk of hypoglycaemia — a target of 48 mmol/mol is recommended. For those on medicines that carry a risk of hypoglycaemia (such as sulphonylureas or insulin), a target of 53 mmol/mol may be more appropriate to reduce the risk of low blood sugar episodes. Targets are always agreed individually between you and your healthcare team, taking your overall health and circumstances into account.

It is important to note that a single HbA1c result should always be interpreted in the context of your overall clinical picture. Factors such as symptoms, other test results, and individual circumstances all contribute to a complete assessment. If your result falls in the non-diabetic hyperglycaemia (NDH) range, this is not a diagnosis of diabetes but a prompt to make lifestyle changes — including dietary improvements, increased physical activity, and weight management — which can significantly reduce your risk of progression to type 2 diabetes.

Accuracy and Limitations of Finger Prick HbA1c Testing

Haemoglobin variants, anaemia, recent blood transfusion, and advanced kidney disease can all distort HbA1c results, making the test unreliable in these situations. MHRA guidance requires point-of-care devices to meet quality assurance standards and be regularly calibrated.

While the HbA1c finger prick test is a valuable and widely used tool, it is important to understand its limitations to ensure results are interpreted appropriately.

Factors that can affect HbA1c accuracy include:

• Haemoglobin variants — Conditions such as sickle cell trait, thalassaemia, or other haemoglobinopathies can produce falsely low or high HbA1c readings. In these cases, alternative tests such as fructosamine may be used

• Anaemia — Iron deficiency anaemia can falsely elevate HbA1c, whilst haemolytic anaemia (where red blood cells are destroyed more rapidly) can falsely lower it

• Recent blood transfusions — These introduce donor red blood cells and can distort the result

• Pregnancy — HbA1c is not recommended for diagnosing gestational diabetes; an oral glucose tolerance test (OGTT) is preferred

• Advanced chronic kidney disease (CKD) — Can affect red blood cell survival and lead to unreliable HbA1c results

• Certain medicines — Including erythropoietin (EPO) therapy and some antiretroviral medicines used in HIV treatment, which can alter red blood cell turnover and affect accuracy

• Acute blood loss or recovery — Can alter the proportion of glycated haemoglobin and produce misleading results

Regarding point-of-care finger prick devices specifically, studies have shown that whilst they are generally reliable, there can be small variations compared to laboratory-analysed venous samples. The MHRA advises that point-of-care devices used in clinical settings must meet quality assurance standards and be regularly calibrated. For this reason, NICE guidance recommends that a result obtained via a point-of-care device should be confirmed with a laboratory venous sample when a new diagnosis of diabetes is being considered, or where there is any clinical uncertainty.

For diagnostic purposes, laboratory venous HbA1c measured in an IFCC-aligned, quality-assured laboratory remains the recommended standard. If you have concerns about a testing device or testing kit, you can report these to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Next Steps After Receiving Your HbA1c Result

Next steps depend on your result: a normal reading requires no immediate action, a prediabetes result may prompt NHS Diabetes Prevention Programme referral, and a diagnostic result leads to confirmatory testing, education, and a care plan. Seek urgent medical attention if symptoms suggest diabetic ketoacidosis.

Receiving your HbA1c result is the beginning of a conversation about your health, not the end. The appropriate next steps will depend on where your result falls and your individual circumstances.

If your result is in the normal range (below 42 mmol/mol): No immediate action is usually required. If you have risk factors for diabetes, your GP may recommend a repeat test in one to three years as part of ongoing monitoring.

If your result indicates non-diabetic hyperglycaemia (NDH) (42–47 mmol/mol): You may be referred to the NHS Diabetes Prevention Programme (NDPP) — also known as 'Healthier You' — a free, evidence-based programme offering structured support with diet, physical activity, and weight management. Evidence from major clinical trials, including the Diabetes Prevention Program and the Finnish Diabetes Prevention Study, indicates that structured lifestyle interventions can substantially reduce the risk of progression to type 2 diabetes in people with NDH. Lifestyle changes at this stage can make a meaningful difference to your long-term health.

If your result is diagnostic of diabetes (48 mmol/mol or above): Your GP will typically arrange a confirmatory laboratory venous HbA1c test (unless symptoms are present and the diagnosis is clear), discuss treatment options, and refer you to a structured diabetes education programme such as DESMOND (for type 2 diabetes). Medication, dietary advice, and regular monitoring will be discussed as part of your care plan.

When to contact your GP promptly:

• If you experience symptoms of high blood sugar (excessive thirst, frequent urination, blurred vision, or unexplained weight loss) before your follow-up appointment

• If you are concerned about a result you have received from a private or pharmacy-based test

• If you are pregnant and have received an elevated result

Urgent and emergency advice: If you or someone you are with develops symptoms that may suggest type 1 diabetes or acute hyperglycaemia — such as vomiting, abdominal pain, drowsiness, rapid or laboured breathing, severe dehydration, or confusion — seek same-day urgent medical assessment. Contact NHS 111, your GP for an urgent same-day appointment, or call 999 and go to A&E if the person is severely unwell. These symptoms may indicate diabetic ketoacidosis (DKA), which requires immediate medical attention.

Not sure if this is normal? Chat with one of our pharmacists →

Regular HbA1c monitoring, combined with healthy lifestyle choices and appropriate medical support, plays a vital role in preventing complications associated with diabetes, including cardiovascular disease, kidney disease, and neuropathy.

Frequently Asked Questions